Since a number of groups are proposing the use of ZIKV as an oncolytic vector [64], this result may warrant further in-depth study to investigate variables such as HDAC inhibitors other than scriptaid, other cancer cell types, or the length of treatment and infection. This evidence concerns the gene HDAC9 and cancer.